Thuja Capital

The rounds this investor is named on, who it invests beside, and where it shows up.

Named on one round in the feed.

We are a leading early-stage venture capital firm dedicated to investing in the most innovative life science companies in Europe.

Venture capitalLeiden, The Netherlandsthujacapital.comSince 2026-11-05

ROUNDS

joined, none as lead

ROUNDS JOINED · USD

$44.9M

across 1 round

LATEST ROUND

Series A · $44.9M · 2026-11-05

CO-INVESTORS

named beside it

Investor

The rounds this investor is named on, who it invests beside, and where it shows up.

Anaheim Bio is unlocking the power of small molecules to transform disease and improve patients' lives.

Series A$44.9M2026-11-055

Company	Round	Amount	Announced	Role
Anaheim Bio Anaheim Bio is unlocking the power of small molecules to transform disease and improve patients' lives.	Series A Verified against 4 of 5 sources	$44.9M	2026-11-05	[ PART ]